Results for “ ”

Entry Author Date Location
Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits 01/22/20 New York
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D 01/15/20 New York
FDA Panel Votes Down Nektar Opioid Painkiller, Asks for More Data 01/14/20 National
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline 01/14/20 New York
Allogene, SpringWorks to Test Drug Combo in Multiple Myeloma Trial 01/13/20 San Francisco
Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More 01/10/20 National
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy 01/08/20 San Francisco
Merck Ramps Up KRAS Chase Through Licensing Deal With Taiho, Astex 01/06/20 New York
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More 01/03/20 National
No More Fish or Fruit: Intrexon Turns SynBio Focus to Human Health 01/02/20 National
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines 12/24/19 National
Bio Roundup: Amarin’s Approval, FTC v. Illumina, a $120M Deal & More 12/20/19 National
Takeda Pays Turnstone $120M to Start Alliance on Viral Cancer Therapies 12/19/19 New York
Zafgen’s Path Forward Is Reverse Merger With Chondrial Therapeutics 12/18/19 Boston
Orbiting Organoids: Research in Space to Unveil New Neurodegeneration Insight 12/18/19 National
Axsome’s Depression Drug Meets Phase 3 Goals, FDA Filing Planned 12/16/19 New York
Amarin’s Fish-Oil Pill Wins FDA Nod to Cut Heart Attack, Stroke Risk 12/13/19 New York
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More 12/13/19 National
Iterum’s Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink 12/11/19 National
KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test 12/10/19 Boston
Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules 12/10/19 National
Perceptive Unveils New $210M Fund to Invest in Early-Stage Biotechs 12/10/19 New York
Merck Makes a Big Blood Cancer Bet With $2.7B Deal for ArQule 12/09/19 New York
Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More 12/06/19 National
FDA Rejects Enzyvant’s Regenerative Therapy for Rare Immune Disorder 12/05/19 Boston
6 Experimental Alzheimer’s Disease Diagnostics Projects Get Funding Boost 12/04/19 New York
Digital Health Survivors & Innovative Incumbents Must Team Up for True Disruption 12/04/19 Raleigh Durham
Roche Notches FDA Nod in Lung Cancer, Amps Up Competition With Merck 12/04/19 San Francisco
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal 12/03/19 San Francisco
Page 1 of 293 next page »